M R Harrigan1, W F Chandler. 1. Department of Surgery, University of Michigan Medical Center, Ann Arbor, USA.
Abstract
OBJECTIVE AND IMPORTANCE: Abducens nerve palsy is a rare and reversible complication associated with percutaneous radiofrequency trigeminal rhizolysis. CLINICAL PRESENTATION: An 86-year-old man developed an abducens nerve palsy immediately after undergoing percutaneous radiofrequency trigeminal rhizolysis for severe trigeminal neuralgia involving all three divisions of the trigeminal nerve. The palsy resolved spontaneously after 2 months. CONCLUSION: This case, in combination with previous reports, suggests that cases of transient sixth nerve palsy associated with percutaneous radiofrequency trigeminal rhizolysis for trigeminal neuralgia are more likely to occur in elderly patients with ophthalmic division involvement.
OBJECTIVE AND IMPORTANCE: Abducens nerve palsy is a rare and reversible complication associated with percutaneous radiofrequency trigeminal rhizolysis. CLINICAL PRESENTATION: An 86-year-old man developed an abducens nerve palsy immediately after undergoing percutaneous radiofrequency trigeminal rhizolysis for severe trigeminal neuralgia involving all three divisions of the trigeminal nerve. The palsy resolved spontaneously after 2 months. CONCLUSION: This case, in combination with previous reports, suggests that cases of transient sixth nerve palsy associated with percutaneous radiofrequency trigeminal rhizolysis for trigeminal neuralgia are more likely to occur in elderly patients with ophthalmic division involvement.
Authors: B G Northcutt; D P Seeburg; J Shin; N Aygun; D A Herzka; D Theodros; C R Goodwin; C Bettegowda; M Lim; A M Blitz Journal: AJNR Am J Neuroradiol Date: 2016-06-30 Impact factor: 3.825
Authors: Matthew J Zdilla; Scott A Hatfield; Kennedy A McLean; Jillian M Laslo; Leah M Cyrus; H Wayne Lambert Journal: J Craniofac Surg Date: 2016-01 Impact factor: 1.046
Authors: Pascal SH Smulders; Michel Amb Terheggen; José W Geurts; Jan Willem Kallewaard Journal: Reg Anesth Pain Med Date: 2021-05-26 Impact factor: 6.288